Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Long Term Outcomes after Autologous Stem Cell Transplantation for Peripheral T Cell Lymphomas

Deepa Jagadeesh, MD MPH, Lisa Rybicki, MS, Donna M Abounader, Brian T. Hill, MD PhD, Robert M Dean, MD, Hien K. Duong, MD, Ronald M. Sobecks, MD, Betty K. Hamilton, MD, Aaron Gerds, MDMS, Christina Ferraro, RN, BSN, Gina Green, RN, Kelly Cherni, RN, Brad Pohlman, MD, Matt E. Kalaycio, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS

Blood (2014) 124 (21): 1200.

https://doi.org/10.1182/blood.V124.21.1200.1200

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation for Follicular Lymphoma in the Era of Rutiximab: Cleveland Clinic Experience

Blood (2014) 124 (21): 1201.

https://doi.org/10.1182/blood.V124.21.1201.1201

Published: 2014

Journal Articles

A Randomized Study Of Music Therapy In Patients Undergoing Autologous Stem Cell Transplant: Decrease In Narcotic Medication Use For Pain Control

Blood (2013) 122 (21): 1693.

https://doi.org/10.1182/blood.V122.21.1693.1693

Published: 2013

Journal Articles

Long-Term Outcome Of Adolescents and Young Adults (AYA) After Autologous Transplantation For Lymphoma; Single Center Experience With Bu-CY-VP16 Conditioning Therapy

Rabi Hanna, MD, Brian J. Bolwell, MD, Ronald Sobecks, MD, Brad Pohlman, MD, Deepa Jagadeesh, MD, MPH, Hien K. Duong, MD, Brian T. Hill, MD, PhD, Kelly Cherni, RN, Christina Ferraro, RN, Gina Green, RN, Betty K. Hamilton, MD, Lisa Rybicki, MS, Matt Kalaycio, MD

Blood (2013) 122 (21): 4644.

https://doi.org/10.1182/blood.V122.21.4644.4644

Published: 2013

Journal Articles

Non-Relapse Mortality (NRM) after Autologous Stem Cell Transplant (ASCT) Is Reduced with Stringent Follow-up Post-Transplant.

Christy Stotler, DO, Lisa Rybicki, Matt Kalaycio, MD, Robert Dean, Edward A. Copelan, MD, Ronald Sobecks, MD, Brad Pohlman, MD, Steven Andresen, DO, John Sweetenham, MD, Kelly Cherni, RN, Josephine Chan, Brian J. Bolwell, MD

Blood (2008) 112 (11): 2155.

https://doi.org/10.1182/blood.V112.11.2155.2155

Published: 2008

Journal Articles

Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Ronald Sobecks, MD, Karl Theil, MD, Lisa Rybicki, MS, Jennifer Bates, BS, Matt Kalaycio, MD, Steven Andresen, DO, Brad Pohlman, MD, Robert M. Dean, MD, John William Sweetenham, MD, Laura Bernhard, RN, Kelly Cherni, RN, Mary Serafin, RN, Karen Sands, RN, Jennifer Kosar, RN, Brian J. Bolwell, MD

Blood (2006) 108 (11): 2960.

https://doi.org/10.1182/blood.V108.11.2960.2960

Published: 2006

Journal Articles

Influence of Killer Immunoglobulin-Like Receptor (KIR) Matching on Achieving T Cell (CD3+) Complete Donor Chimerism (CDC) in Related Donor Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).

Ronald Sobecks, MD, Edward J. Ball, PhD, Medhat Askar, MD, PhD., Karl Theil, MD, Lisa Rybicki, MS, Dawn Thomas, CHS, Jennifer Bates, BS, Matt Kalaycio, MD, Steven Andresen, DO, Brad Pohlman, MD, Robert M. Dean, MD, John William Sweetenham, MD, Laura Bernhard, RN, Kelly Cherni, RN, Jaroslaw P. Maciejewski, MD, MS, Brian J. Bolwell, MD

Blood (2006) 108 (11): 3012.

https://doi.org/10.1182/blood.V108.11.3012.3012

Published: 2006

Journal Articles

Patients Mobilizing Large Numbers of CD34+ Cells ("Super-Mobilizers") Have Improved Survival in Autologous Stem Cell Transplantation for Lymphoid Malignancies.

Brian J. Bolwell, MD, Brad Pohlman, MD, Lisa Rybicki, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Robert M. Dean, MD, Laura Bernhard, RN, Kelly Cherni, RN, Christina Ferraro, RN, Jenny Bates, Stacey Brown, John William Sweetenham, MD

Blood (2006) 108 (11): 3378.

https://doi.org/10.1182/blood.V108.11.3378.3378

Published: 2006

NARROW

Long Term Outcomes after Autologous Stem Cell Transplantation for Peripheral T Cell Lymphomas

Autologous Stem Cell Transplantation for Follicular Lymphoma in the Era of Rutiximab: Cleveland Clinic Experience

A Randomized Study Of Music Therapy In Patients Undergoing Autologous Stem Cell Transplant: Decrease In Narcotic Medication Use For Pain Control

Long-Term Outcome Of Adolescents and Young Adults (AYA) After Autologous Transplantation For Lymphoma; Single Center Experience With Bu-CY-VP16 Conditioning Therapy

Non-Relapse Mortality (NRM) after Autologous Stem Cell Transplant (ASCT) Is Reduced with Stringent Follow-up Post-Transplant.

Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Influence of Killer Immunoglobulin-Like Receptor (KIR) Matching on Achieving T Cell (CD3+) Complete Donor Chimerism (CDC) in Related Donor Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).

Patients Mobilizing Large Numbers of CD34+ Cells ("Super-Mobilizers") Have Improved Survival in Autologous Stem Cell Transplantation for Lymphoid Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only